These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3618686)

  • 1. Digoxin-like immunoreactive substance in fetuses with and without cardiac pathology.
    Weiner CP; Landas S; Persoon TJ
    Am J Obstet Gynecol; 1987 Aug; 157(2):368-71. PubMed ID: 3618686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic factor, digoxin-like immunoreactive substance, norepinephrine, epinephrine, and plasma renin activity in human fetuses and their alteration by fetal disease.
    Weiner CP; Robillard JE
    Am J Obstet Gynecol; 1988 Dec; 159(6):1353-60. PubMed ID: 2974684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of digoxin in the blood of pregnant women, fetuses and neonates before and during anti-arrhythmic therapy, using four immunochemical methods.
    Schlebusch H; von Mende S; Grünn U; Gembruch U; Bald R; Hansmann M
    Eur J Clin Chem Clin Biochem; 1991 Jan; 29(1):57-66. PubMed ID: 2049475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin-like immunoreactive substance in pregnancy.
    González AR; Phelps SJ; Cochran EB; Sibai BM
    Am J Obstet Gynecol; 1987 Sep; 157(3):660-4. PubMed ID: 2820228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal and fetal digoxin-like immunoreactive factor in elective cesarean sections and spontaneous vaginal delivery.
    Zimmer EZ; Jakobi P; Weissman A; Cligher J; Krivoy N
    Eur J Obstet Gynecol Reprod Biol; 1990; 36(1-2):53-8. PubMed ID: 2163927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin-like immunoreactive substance in sera from umbilical cord, infants and mothers.
    Chen MR; Wu WH; Sung TC; Chen PN; Wang EY; Yang YC
    Taiwan Yi Xue Hui Za Zhi; 1987 Sep; 86(9):952-6. PubMed ID: 3694167
    [No Abstract]   [Full Text] [Related]  

  • 7. Endogenous digoxin-like immunoreactivity during pregnancy and at birth.
    Lupoglazoff JM; Jacqz-Aigrain E; Guyot B; Chappey O; Blot P
    Br J Clin Pharmacol; 1993 Mar; 35(3):251-4. PubMed ID: 8471401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of atrial natriuretic peptide and digoxin-like immunoreactive substance during pregnancy.
    Shrivastav P; Gill DS; D'Souza V; O'Brien PM; Dandona P
    Clin Chem; 1988 May; 34(5):977-80. PubMed ID: 2967132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of gestational age and preeclampsia on the presence and magnitude of serum endogenous digoxin-like immunoreactive substance(s).
    Phelps SJ; Cochran EB; Gonzalez-Ruiz A; Tolley EA; Hammond KD; Sibai BM
    Am J Obstet Gynecol; 1988 Jan; 158(1):34-9. PubMed ID: 3337179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum level of digoxin-like immunoreactive substances in newborn infants in the first two weeks of life, in umbilical cord blood and in pregnant patients at the time of labor].
    Gawaz MP; Schreiber R; Vogt W; Genz T; Kellner M
    Klin Padiatr; 1990; 202(1):31-6. PubMed ID: 2156105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal supraventricular tachycardia and hydrops fetalis: combined intensive, direct, and transplacental therapy.
    Hallak M; Neerhof MG; Perry R; Nazir M; Huhta JC
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):523-5. PubMed ID: 1870815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct treatment of fetal supraventricular tachycardia after failed transplacental therapy.
    Weiner CP; Thompson MI
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 1):570-3. PubMed ID: 3348317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endogenous digoxin-like substance (nonspecific interference or a new hormone?)].
    Kovács L; Lichardus B; Bircák J; Benetínová J; Ponecová M; Masurová A; Stefaníková J
    Cesk Pediatr; 1989 Feb; 44(2):73-5. PubMed ID: 2720827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy.
    Parilla BV; Strasburger JF; Socol ML
    Am J Perinatol; 1996 Nov; 13(8):483-6. PubMed ID: 8989479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration of digoxin-like immunoreactive substance in patients with preeclampsia and its relation to severity of pregnancy-induced hypertension.
    Kaminski K; Rechberger T
    Am J Obstet Gynecol; 1991 Sep; 165(3):733-6. PubMed ID: 1892203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin-like-immunoreactive substance: non-specific interference or a new hormone?
    Clerico A; Ghione S; Balzan S; Del Chicca MG
    J Nucl Med Allied Sci; 1984; 28(4):297-301. PubMed ID: 6100187
    [No Abstract]   [Full Text] [Related]  

  • 17. Intrauterine digoxin treatment of fetal paroxysmal tachycardia. Case report.
    Lingman G; Ohrlander S; Ohlin P
    Br J Obstet Gynaecol; 1980 Apr; 87(4):340-2. PubMed ID: 7426504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
    Mojaverian P; Green PJ; Jhangiania RK; Chase GD
    J Pharm Biomed Anal; 1989; 7(5):585-92. PubMed ID: 2490762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplacental passage of digoxin in severe Rhesus immunization.
    Kanhai HH; van Kamp IL; Moolenaar AJ; Gravenhorst JB
    J Perinat Med; 1990; 18(5):339-43. PubMed ID: 2127286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous digoxin-like substance(s) associated with uneventful and high-risk pregnancies.
    Koren G; Farine D; Grundmann H; Heyes J; Soldin S; Taylor J; MacLeod SM
    Dev Pharmacol Ther; 1988; 11(2):82-7. PubMed ID: 3371149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.